Home > Insider Trading > Filing (0001181431-13-014202)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401923	Map Pharmaceuticals Inc.	MAPP	Pharmaceutical Preparations (2834)	200507047

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236451	Geraldine Henwood	C/O Map Pharmaceuticals, Inc. 2400 Bayshore Parkway, Suite 200 Mountain View CA 94043		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-28	2,500	$11.69	2,500	No	4	M	Direct
Common Stock	Acquisiton	2013-02-28	7,500	$12.19	10,000	No	4	M	Direct
Common Stock	Disposition	2013-02-28	10,000	$25.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-02-28	2,500	$0.00	2,500	$11.69
Common Stock	Stock Option (Right to Buy)	Disposition	2013-02-28	7,500	$0.00	7,500	$12.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000		2022-05-16	No	4	M	Direct
0		2018-05-21	No	4	M	Direct

Footnotes

The transaction was made pursuant to a 10b5-1 trading plan in effect at the time of the transaction.
The shares subject to this stock option become exercisable as they vest. Twenty-five percent (25%) of the total number of shares vest and become exercisable on the first anniversary of the grant date. Thereafter, the remaining shares vest and become exercisable cumulatively in equal monthly installments over the following thirty-six (36) months so that all shares become vested and fully exercisable on the fourth anniversary of the grant date.
Fully exercisable.